Effect of calcium dobesilate in patients with subclinical diabetic macular oedema: the CADODIAME study
Por:
Simo-Servat, O, Cordero-Vazquez, E, Brosa, H, Simo-Servat, A, Barraso, M, Valldeperas, X, Barahona, M, Garcia-Arumi, J, Rivas, M, Hernandez, C, Lehr, L, Zingg, D and Simo, R
Publicada:
1 sep 2021
Resumen:
Filiaciones:
Simo-Servat, O:
Hosp Valle De Hebron, Dept Endocrinol, Barcelona, Spain
Cordero-Vazquez, E:
Hosp Valle De Hebron, Dept Endocrinol, Barcelona, Spain
Brosa, H:
Hosp Valle De Hebron, Ophtalmol Dept, Barcelona, Spain
Simo-Servat, A:
Hosp Mutua Terrassa, Dept Endocrinol, Terrassa, Spain
Barraso, M:
Hosp Mutua Terrassa, Ophtalmol Dept, Terrassa, Spain
:
Hosp Badalona Germans Trias & Pujol, Ophtalmol Dept, Badalona, Spain
Barahona, M:
Hosp Mutua Terrassa, Dept Endocrinol, Terrassa, Spain
Garcia-Arumi, J:
Hosp Valle De Hebron, Ophtalmol Dept, Barcelona, Spain
Rivas, M:
Hosp Valle De Hebron, Dept Endocrinol, Barcelona, Spain
Hernandez, C:
Hosp Valle De Hebron, Dept Endocrinol, Barcelona, Spain
Lehr, L:
OM Pharma, Geneva, Switzerland
Zingg, D:
OM Pharma, Geneva, Switzerland
Simo, R:
Hosp Valle De Hebron, Dept Endocrinol, Barcelona, Spain
|